Experts Forecast 2024, Part 3: Precision Medicine for Cancer Treatment
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
Tag: combination therapies
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Recent advances in cancer research has led to enormous progress against many cancer types. From 1991 to 2015, we...
Radiotherapy is a mainstay of cancer treatment. In recent years, improved technology has allowed many cancer patients to receive...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
Patients have long benefited from combination treatments—whether combining surgery with chemotherapy and radiation, or combining chemotherapy agents in succession.